Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical significance of some genetic polymorphisms of cytochrome P-450: family CYP1 and subfamilies CYP2A, CYP2B and CYP2C].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego - 1 Mar 2009

Wojtczak Anna, Skretkowicz Jadwiga

Abstract excerpt

The essence of pharmacogenetic studies is to provide a scientific explanation for personal differences in the process of drugs metabolism. Polymorphism of drugs biotransformation is clinically significant from the point of view of the effectiveness and safety of pharmacotherapy and an increased risk of some illnesses. The paper presents molecular mechanisms and clinical implication of several genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Biotransformation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclophilins

Share to Cytochrome P-450 CYP1A1

Share to Cytochrome P-450 CYP1B1

Share to Cytochrome P-450 Enzyme System

Share to Steroid Hydroxylases

Share to Xenobiotics

Source

Identifiers

PMID: 19388543

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical significance of some genetic polymorphisms of cytochrome P-450: family CYP1 and subfamilies CYP2A, CYP2B and CYP2C].PMID 19388543Read ↗

[Clinical significance of some genetic polymorphisms of cytochrome P-450 subfamilies CYP2D, CYP2E and CYP3A--part II].Semantic proximity Read ↗

[Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis].Semantic proximity Read ↗

[Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme].Semantic proximity Read ↗

Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.Semantic proximity Read ↗

[Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].Semantic proximity Read ↗

Advances in human cytochrome p450 and personalized medicine.Semantic proximity Read ↗

Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.Semantic proximity Read ↗

[Pharmacogenetics: pharmacokinetics and clinical implications].Semantic proximity Read ↗

[Genetic polymorphisms in drug-metabolizing enzymes].Semantic proximity Read ↗

[Genetic polymorphism of drug metabolizing enzymes].Semantic proximity Read ↗

Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and AtherosclerosisSemantic proximity Read ↗

Cytochrome P450 Enzyme System: Genetic Polymorphisms and Impact on Clinical PharmacologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.